Urinary excretion of advanced glycation endproducts in patients with type 2 diabetes and various stages of proteinuria (Q44116691)

29 November 2017

Urinary excretion of advanced glycation endproducts in patients with type 2 diabetes and various stages of proteinuria (English)

1 reference

29 November 2017

1 reference

Turk N

1

1 reference

29 November 2017

Mornar A

series ordinal

2

1 reference

29 November 2017

Mrzljak V

series ordinal

3

1 reference

29 November 2017

Turk Z

series ordinal

4

1 reference

29 November 2017

language of work or name

1 reference

1 April 2004

1 reference

29 November 2017

Diabetes and Metabolism

1 reference

29 November 2017

30

1 reference

29 November 2017

2

1 reference

29 November 2017

187-192

1 reference

Advanced glycation end-products: a review

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970106-4

7 January 2021

Role of the Maillard reaction in aging of tissue proteins. Advanced glycation end product-dependent increase in imidazolium cross-links in human lens proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970106-4

7 January 2021

Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970106-4

7 January 2021

Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970106-4

7 January 2021

Protein modification by a Maillard reaction intermediate methylglyoxal. Immunochemical detection of fluorescent 5-methylimidazolone derivatives in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970106-4

7 January 2021

Advanced glycation end products in serum predict changes in the kidney morphology of patients with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970106-4

7 January 2021

Activation of tubular epithelial cells in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970106-4

7 January 2021

An inhibitor of advanced glycation end product formation reduces N epsilon-(carboxymethyl)lysine accumulation in glomeruli of diabetic rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970106-4

7 January 2021

The AGE-receptor in the pathogenesis of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970106-4

7 January 2021

Specific fluorescence assay for advanced glycation end products in blood and urine of diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970106-4

7 January 2021

The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970106-4

7 January 2021

N(epsilon)-(carboxymethyl)lysine levels in patients with type 2 diabetes: role of renal function

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970106-4

7 January 2021

Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970106-4

7 January 2021

N(carboxymethyl)lysine as a biomarker for microvascular complications in type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970106-4

7 January 2021

Detection of autoantibodies against advanced glycation endproducts and AGE-immune complexes in serum of patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970106-4

7 January 2021

Products of advanced glycation in patients with type 2 diabetes and vascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970106-4

7 January 2021

Glycaemic control and in vivo non-oxidative Maillard reaction: urinary excretion of pyrraline in diabetes patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970106-4

7 January 2021

Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970106-4

7 January 2021

Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970106-4

7 January 2021

Microvascular basement membranes in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970106-4

7 January 2021

10.1016/S1262-3636(07)70106-4

Identifiers

DOI

1 reference

release_pto2n5jsyncs5i3mkfb7b275hq

29 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pto2n5jsyncs5i3mkfb7b275hq

24 November 2022

mapped directly with Wikidata item

1 reference